Literature DB >> 1493939

Granulocyte-macrophage colony-stimulating factor (GM-CSF): a variety of possible applications in clinical medicine.

M Weiss, B H Belohradsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1493939     DOI： 10.1007/bf01705023

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  10 in total

Review 1.  Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2).

Authors:  G J Lieschke; A W Burgess
Journal:  N Engl J Med       Date:  1992-07-09       Impact factor: 91.245

Review 2.  Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1).

Authors:  G J Lieschke; A W Burgess
Journal:  N Engl J Med       Date:  1992-07-02       Impact factor: 91.245

Review 3.  G-CSF: status quo and new indications.

Authors:  F Herrmann
Journal:  Infection       Date:  1992 Jul-Aug       Impact factor: 3.553

4.  New hats for hematopoietic hormones.

Authors:  C A Sieff
Journal:  Exp Hematol       Date:  1991-10       Impact factor: 3.084

5.  Primary structure and functional expression of rat and human stem cell factor DNAs.

Authors:  F H Martin; S V Suggs; K E Langley; H S Lu; J Ting; K H Okino; C F Morris; I K McNiece; F W Jacobsen; E A Mendiaz
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

6.  Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms.

Authors:  D M Anderson; S D Lyman; A Baird; J M Wignall; J Eisenman; C Rauch; C J March; H S Boswell; S D Gimpel; D Cosman
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

7.  Recombinant human erythropoietin in the treatment of infants with anaemia of prematurity.

Authors:  D S Halpérin; M Félix; P Wacker; G Lacourt; J F Babel; M Wyss
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

8.  Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome.

Authors:  J E Groopman; R T Mitsuyasu; M J DeLeo; D H Oette; D W Golde
Journal:  N Engl J Med       Date:  1987-09-03       Impact factor: 91.245

9.  Treatment of the anemia of progressive renal failure with recombinant human erythropoietin.

Authors:  J W Eschbach; M R Kelly; N R Haley; R I Abels; J W Adamson
Journal:  N Engl J Med       Date:  1989-07-20       Impact factor: 91.245

10.  Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase I/II trial.

Authors:  A Ganser; B Völkers; J Greher; O G Ottmann; F Walther; R Becher; L Bergmann; G Schulz; D Hoelzer
Journal:  Blood       Date:  1989-01       Impact factor: 22.113
  10 in total
  1 in total

1.  The effect of enzymatically polymerised polyphenols on CD4 binding and cytokine production in murine splenocytes.

Authors:  Daisuke Yamanaka; Yumi Tamiya; Masuro Motoi; Ken-ichi Ishibashi; Noriko N Miura; Yoshiyuki Adachi; Naohito Ohno
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.